NCT06658808 Efficacy-Implementation Study for PC CARES in Rural Alaska
| NCT ID | NCT06658808 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Michigan |
| Condition | Suicide Prevention |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,075 participants |
| Start Date | 2024-09-12 |
| Primary Completion | 2029-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,075 participants in total. It began in 2024-09-12 with a primary completion date of 2029-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This participatory, pragmatic efficacy-implementation trial evaluates the impact of Promoting Community Conversations About Research to End Suicide (PC CARES) to evaluate Learning Circle (LC) participant outcomes (AIM#1), community-wide diffusion effects, and efficacy by tracking youth impact (AIM#2), while finding sustainable ways to scale PC CARES to other Alaska Native (AN) communities (AIM#3).
Eligibility Criteria
Inclusion Criteria: * Anyone aged 12 and over who lives or works in the designated communities may participate in this study.
Contact & Investigator
Lisa Wexler, PhD
PRINCIPAL INVESTIGATOR
Univer
Frequently Asked Questions
Who can join the NCT06658808 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, studying Suicide Prevention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06658808 currently recruiting?
Yes, NCT06658808 is actively recruiting participants. Contact the research team at lwexler@umich.edu for enrollment information.
Where is the NCT06658808 trial being conducted?
This trial is being conducted at Fairbanks, United States, Ann Arbor, United States.
Who is sponsoring the NCT06658808 clinical trial?
NCT06658808 is sponsored by University of Michigan. The principal investigator is Lisa Wexler, PhD at Univer. The trial plans to enroll 1,075 participants.